Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: A systematic review and meta-analysis

European Urology

Volumn 67, Issue 4, 2015, Pages 704-713

  Perera, Marlon ^a,b   Roberts, Matthew J ^a,b,c   Doi, Suhail A R ^c,d   Bolton, Damien ^e,f  

^a MACKAY BASE HOSPITAL   (Australia)

^b Thoracic Society of Australia and New Zealand   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d PRINCESS ALEXANDRA HOSPITAL   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f AUSTIN HOSPITAL   (Australia)

Author keywords

Benign prostatic hyperplasia; Lower urinary tract symptoms; Minimally invasive surgical therapy; Prostate; Prostatic urethral lift; Urethra; Urolift

Indexed keywords

ALTERNATIVE MEDICINE; EJACULATION DISORDER; ERECTILE DYSFUNCTION; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MALE; META ANALYSIS; MICTURITION; MINIMALLY INVASIVE SURGERY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATIC URETHRAL LIFT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEXUAL FUNCTION; SEXUAL HEALTH; SYSTEMATIC REVIEW; URETHRA SURGERY; URINE FLOW RATE; ADVERSE EFFECTS; AGED; COMPLICATION; LOWER URINARY TRACT SYMPTOMS; MALE GENITAL SYSTEM SURGERY; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; PROSTATIC HYPERPLASIA; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TREATMENT OUTCOME; URETHRA;

AGED; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; MINIMALLY INVASIVE SURGICAL PROCEDURES; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TREATMENT OUTCOME; URETHRA; UROLOGIC SURGICAL PROCEDURES, MALE;

EID: 84923096546     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.10.031     Document Type: Review

References (53)

1. C.G. Roehrborn Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations Rev Urol 10 2008 14 25
2. J. Nordling Efficacy and safety of two doses (10 and 15 mg) of alfuzosin or tamsulosin (0.4 mg) once daily for treating symptomatic benign prostatic hyperplasia BJU Int 95 2005 1006 1012
3. M. Rom, G. Schatzl, N. Swietek, E. Rucklinger, and C. Kratzik Lower urinary tract symptoms and depression BJU Int 110 2012 E918 E921
4. H.H. Woo, P.T. Chin, and T.A. McNicholas Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) BJU Int 108 2011 82 88
5. Speakman M, Kirby R, Doyle S, Ioannou C. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK. BJU Int. In press. http://dx.doi.org/10.1111/bju.12745
6. J.-N. Cornu, O. Cussenot, F. Haab, and B. Lukacs A widespread population study of actual medical management of lower urinary tract symptoms related to benign prostatic hyperplasia across Europe and beyond official clinical guidelines Eur Urol 58 2010 450 456
7. K.M. Verhamme, J.P. Dieleman, G.S. Bleumink, J.L. Bosch, B.H. Stricker, and M.C. Sturkenboom Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph project Eur Urol 44 2003 539 545
8. M. Oelke, A. Bachmann, and A. Descazeaud EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction Eur Urol 64 2013 118 140
9. J. Rassweiler, D. Teber, R. Kuntz, and R. Hofmann Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention Eur Urol 50 2006 969 980 discussion 980
10. K.T. McVary, C.G. Roehrborn, and A.L. Avins Update on AUA guideline on the management of benign prostatic hyperplasia J Urol 185 2011 1793 1803
11. S.A. Ahyai, P. Gilling, and S.A. Kaplan Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement Eur Urol 58 2010 384 397
12. J. Barkin, J. Giddens, P. Incze, R. Casey, S. Richardson, and S. Gange UroLift system for relief of prostate obstruction under local anesthesia Can J Urol 19 2012 6217 6222
13. T.A. McNicholas, H.H. Woo, and P.T. Chin Minimally invasive prostatic urethral lift: surgical technique and multinational experience Eur Urol 64 2013 292 299
14. A. Liberati, D.G. Altman, and J. Tetzlaff The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 339 2009 b2700
15. J.P. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions 2008 Wiley-Blackwell Hoboken, NJ
16. Higgins JP, Altman DG, Sterne JA. Assessing risk of bias in included studies. In: Higgins JP, Green S, eds. Cochrane handbook for systematic reviews of interventions, ed 5.1.0. Cochrane Collaboration Web site. http://handbook.cochrane.org/.
17. C.R. Ramsay, L. Matowe, R. Grilli, J.M. Grimshaw, and R.E. Thomas Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies Int J Technol Assess Health Care 19 2003 613 623
18. S.A. Doi, and L. Thalib A quality-effects model for meta-analysis Epidemiology 19 2008 94 100
19. M.J. Roberts, D.A. Williamson, P. Hadway, S.A. Doi, R.A. Gardiner, and D.L. Paterson Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: a bias-adjusted meta-analysis Int J Antimicrob Agents 43 2014 301 309
20. S.A. Doi, J.J. Barendregt, and E.L. Mozurkewich Meta-analysis of heterogeneous clinical trials: an empirical example Contemp Clin Trials 32 2011 288 298
21. M. Lipsey, and D. Wilson Practical meta-analysis 2000 Sage Thousand Oaks, CA
22. J. Cohen Statistical power analysis for the behavioral sciences ed 2 1988 Lawrence Erlbaum Associates London, UK
23. B. Takkouche, C. Cadarso-Suarez, and D. Spiegelman Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis Am J Epidemiol 150 1999 206 215
24. C.G. Roehrborn, S.N. Gange, and N.D. Shore The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the LIFT study J Urol 190 2013 2161 2167
25. K.T. McVary, S.N. Gange, and N.D. Shore Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift J Sex Med 11 2014 279 287
26. A.L. Cantwell, W.K. Bogache, and S.F. Richardson Multicentre prospective crossover study of the 'prostatic urethral lift' for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia BJU Int 113 2014 615 622
27. N. Shore, S. Freedman, and S. Gange Prospective multi-center study elucidating patient experience after prostatic urethral lift Can J Urol 21 2014 7094 7101
28. P.G. Abad, A.C. del Peso, B.S. Ojas, and M.F. Arjona Urolift®, a new minimally invasive treatment for patients with low urinary tract symptoms secondary to BPH. Preliminary results [in Spanish] Arch Esp Urol 66 2013 584 591
29. H.H. Woo, D.M. Bolton, and E. Laborde Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia J Sex Med 9 2012 568 575
30. P.T. Chin, D.M. Bolton, and G. Jack Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia Urology 79 2012 5 11
31. D. Dindo, N. Demartines, and P.A. Clavien Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2004 205 213
32. T. Lourenco, N. Armstrong, and J. N'Dow Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement Health Technol Assess 12 2008 iii ix-x, 1-146, 169-515
33. I.A. Thangasamy, V. Chalasani, A. Bachmann, and H.H. Woo Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis from 2002 to 2012 Eur Urol 62 2012 315 323
34. J. Teng, D. Zhang, and Y. Li Photoselective vaporization with the green light laser vs transurethral resection of the prostate for treating benign prostate hyperplasia: a systematic review and meta-analysis BJU Int 111 2013 312 323
35. J.D. McConnell, C.G. Roehrborn, and O.M. Bautista The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia N Engl J Med 349 2003 2387 2398
36. K. Namiki, H. Shiozawa, M. Tsuzuki, Y. Mamiya, T. Matsumoto, and M. Miki Efficacy of transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia Int J Urol 6 1999 341 345
37. T. Ohigashi, K. Nakamura, J. Nakashima, S. Baba, and M. Murai Long-term results of three different minimally invasive therapies for lower urinary tract symptoms due to benign prostatic hyperplasia: comparison at a single institute Int J Urol 14 2007 326 330
38. Y.W. Lim, K.J. Tay, and H.S.S. Ho The minimally invasive treatments for benign prostrate hyperplasia Proc Singapore Healthcare 23 2014 65 73
39. D.M. Bouchier-Hayes, S. Van Appledorn, P. Bugeja, H. Crowe, B. Challacombe, and A.J. Costello A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up BJU Int 105 2010 964 969
40. B. Lukacs, J. Loeffler, and F. Bruyère Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial Eur Urol 61 2012 1165 1173
41. N. Takeshima, T. Sozu, A. Tajika, Y. Ogawa, Y. Hayasaka, and T.A. Furukawa Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference? BMC Med Res Methodol 14 2014 30
42. K. McVary Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology BJU Int 97 Suppl 2 2006 23 28 discussion 44-5
43. E.O. Laumann, A. Paik, and D.B. Glasser A cross-national study of subjective sexual well-being among older women and men: findings from the Global Study of Sexual Attitudes and Behaviors Arch Sex Behav 35 2006 145 161
44. R. Rosen, J. Altwein, and P. Boyle Lower urinary tract symptoms and male sexual dysfunction: the Multinational Survey of the Aging Male (MSAM-7) Eur Urol 44 2003 637 649
45. T.J. Wilt, R. Mac Donald, and I. Rutks Tamsulosin for benign prostatic hyperplasia Cochrane Database Syst Rev 2003 CD002081
46. R.C. Rosen, and J.M. Fitzpatrick Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia BJU Int 104 2009 974 983
47. M.M. van Dijk, J.J. de la Rosette, and M.C. Michel Effects of alpha(1)-adrenoceptor antagonists on male sexual function Drugs 66 2006 287 301
48. A. Shelbaia, W.M. Elsaied, H. Elghamrawy, A. Abdullah, and M. Salaheldin Effect of selective alpha-blocker tamsulosin on erectile function in patients with lower urinary tract symptoms due to benign prostatic hyperplasia Urology 82 2013 130 135
49. R.M. Hoffman, M. Monga, and S.P. Elliott Microwave thermotherapy for benign prostatic hyperplasia Cochrane Database Syst Rev 2012 CD004135
50. R.W. Frieben, H.C. Lin, P.P. Hinh, F. Berardinelli, S.E. Canfield, and R. Wang The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: a systematic review Asian J Androl 12 2010 500 508
51. R.M. Hoffman, R. MacDonald, and T.J. Wilt Laser prostatectomy for benign prostatic obstruction Cochrane Database Syst Rev 2004 CD001987
52. D.J. Martin, and J.P. Mulhall Enlarging the scope of managing benign prostatic hyperplasia: addressing sexual function and quality of life Int J Clin Pract 59 2005 579 590
53. S.H. Alloussi, C. Lang, R. Eichel, and S. Alloussi Ejaculation-preserving transurethral resection of prostate and bladder neck: short- and long-term results of a new innovative resection technique J Endourol 28 2014 84 89